We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Merck moves into biotech.
- Authors
Kling, Jim
- Abstract
The article reports about the plans of Merck & Co. Inc. to purchase the protein manufacturing firms GlycoFi Inc. for $400 million and Abmaxis Inc. for $80 million in the U.S. This move is one of the latest in a series of acquisitions that had seen other pharmaceutical giants attempt to lock up positions in biotech drug discovery. These moves represent an acknowledgment that biologics are likely to take a large percentage in the future pharmaceutical industry.
- Subjects
MERGERS &; acquisitions; MERCK &; Co. Inc.; GLYCOFI Inc.; ABMAXIS Inc.; BIOTECHNOLOGY; PHARMACEUTICAL industry
- Publication
Nature Biotechnology, 2006, Vol 24, Issue 7, p730
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0706-730